UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
(Amendment No. 2)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 28, 2021
HIMALAYA TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its Charter)
| nevada | 000-55282 | 26-0841675 | ||
(State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
831 W North Ave., Pittsburgh, PA 15233
(Address of principal executive offices)
(630) 708-0750
(Registrant’s Telephone Number)
1 E Erie St, Ste 525 Unit #2420, Chicago, IL 60611
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
| Common | HMLA | OTC Pink Current |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☒
Himalaya Technologies, Inc. a/ka Homeland Resources Ltd. is referred to herein as “Himalaya”, “we”, “us”, or “the Company”.
Background
This Second Amendment to Form 8-K filed November 28, 2021 notifies investors that we have agreed to cancel and unwind our previously completed investment in GenBio, Inc. Accordingly, GenBio has agreed to return 99,686 Series B Preferred shares previously issued to them which could have converted into 99,685,794 common shares, thereby reducing our diluted shares outstanding by that amount.
Item 8.01 Other Events.
On November 28, 2021, Himalaya Technologies, Inc. a/k/a Homeland Resources Ltd. (https://www.himalayatechnologies.com/), a minority investment of FOMO CORP. (OTC: FOMC; https://www.fomoworldwide.com/), purchased 13,883,812 shares of GenBio, Inc. (“GenBio”; https://genbioinc.com/) common stock using consideration of 99,686 Himalaya Series B preferred shares, representing 19.9% ownership of GenBio. The Companies intend to collaborate on nutraceutical products offering anti-inflammatory and reduced blood pressure applications including powders, enhanced honey extracts, droplets and canned beverages.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HIMALAYA TECHNOLOGIES, INC. a/k/a HOMELAND RESOURCES LTD. | ||
| Date: May 16, 2023 | By: | /s/ Vikram Grover |
| Vikram Grover | ||
| Chief Executive Officer | ||